-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Alx Oncology Holdings Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2024.
- Alx Oncology Holdings Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 52.7M shares, a 28.1% increase year-over-year.
- Alx Oncology Holdings Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 43M shares, a 5.62% increase from 2022.
- Alx Oncology Holdings Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 40.7M shares, a 0.97% increase from 2021.
- Alx Oncology Holdings Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 40.3M shares, a 118% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)